Position in OMER
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,142,550
-$1,762,360 QoQ
Shares Held
202,893
-10.7% QoQ
Ownership
0.280%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.86692493087489.ToString("F0")%
Shared 0.ToString("F0")%
None 0.13307506912510536.ToString("F0")%
Common Shares in OMER Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. OMER ranks #214 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in OMER
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,142,550 | 202,893 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,904,910 | 227,294 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $1,377,956 | 336,087 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $761,892 | 253,964 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,489,093 | 181,155 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $2,090,607 | 211,600 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $707,294 | 178,160 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $367,453 | 90,506 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $165,092 | 47,853 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $136,871 | 41,857 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $310,985 | 106,502 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $762,246 | 140,119 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $1,111,508 | 239,034 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $55,458 | 24,539 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $62,662 | 19,893 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $307,741 | 111,906 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $1,203,411 | 200,235 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,313,558 | 204,286 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $4,198,709 | 304,475 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $9,517,173 | 641,319 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $14,337,793 | 805,494 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $2,217,850 | 155,203 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,900,538 | 187,986 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $4,969,957 | 337,633 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $4,383,674 | 327,874 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||